- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 32.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 34.52M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 25.69M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $613K |
| Capex | Q1 2026 · Mar 31, 2025 | $307K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$7.64M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$5.84M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $28.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $11.58M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$10.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$31.46M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $10.22M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$12.27M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $12.01M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.08M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $51.12M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $57.22M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $30.52M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $15.31M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $40.43M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $25.76M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.12 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.26 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.99M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $3.12M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.95M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $2.92M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.29M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.41M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$6.8M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $15K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $1.33M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $17K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $813K |
| Revenue | Q1 2026 · Mar 31, 2026 | $32K |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.14M |